electronic data collection tool (Alexion Phrama)
90
Structured Review
Alexion Phrama
electronic data collection tool
Electronic Data Collection Tool, supplied by Alexion Phrama, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/electronic+data+collection+tool/electronic+data+collection+tool/pmc10495927__jamaneurol___e232851___s002-1140-10-23
Average 90 stars, based on 1 article reviews
Electronic Data Collection Tool, supplied by Alexion Phrama, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/electronic+data+collection+tool/electronic+data+collection+tool/pmc10495927__jamaneurol___e232851___s002-1140-10-23
Average 90 stars, based on 1 article reviews
electronic data collection tool - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Efficacy and Safety of Ravulizumab, a Complement C5 Inhibitor, in Adults With Amyotrophic Lateral Sclerosis Article Snippet: • If a site receives a report of a new SAE from a study patient or receives updated data on a previously reported SAE after the electronic data collection tool has been taken off-line, then the site can report this information on a paper SAE form to the Article Title: A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial Article Snippet: Article Title: Efficacy and Safety of Ravulizumab, a Complement C5 Inhibitor, in Adults With Amyotrophic Lateral Sclerosis Article Snippet: Serious Adverse Event Reporting to Alexion or designee via an Article Title: A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial Article Snippet: • The primary mechanism for reporting an |